Cerebral vascular malformations

Gene: NOS3

Amber List (moderate evidence)

NOS3 (nitric oxide synthase 3)
EnsemblGeneIds (GRCh38): ENSG00000164867
EnsemblGeneIds (GRCh37): ENSG00000164867
OMIM: 163729, Gene2Phenotype
NOS3 is in 3 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

PMID:36941667 analysed six patients from a cohort of 126 consecutive unrelated probands with Moyamoya angiopathy (MMA) of unknown etiology. Two of these six patients were identified with homozygous NOS3 variants, of which one is missense (c.1942T> C, p.(Cys648Arg)) and the other is splice-site variant (c.1502 + 1G > C). Both probands with NOS3 variants suffered from an infant-onset and severe MMA associated with posterior cerebral artery steno-occlusive lesions. There is also some functional evidence available for both variants.

PMID:37383439 reported six patients with Moyamoya disease, of which one patient was identified with monoallelic missense NOS3 variant (c.1684G>A; p.Glu562Lys.

In summary, there are two unrelated cases and some functional evidence available for the association of biallelic variants with MMA. However, there is only one case with monoallelic NOS3 variant. The pathogenicity of this monoallelic variant was not explored in detail in the publication
Sources: Literature
Created: 1 May 2025, 8:27 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Moyamoya disease, MONDO:0016820

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Moyamoya disease, MONDO:0016820
OMIM
163729
Clinvar variants
Variants in NOS3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

1 May 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: nos3 has been classified as Amber List (Moderate Evidence).

1 May 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: nos3 has been classified as Amber List (Moderate Evidence).

1 May 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: NOS3 was added gene: NOS3 was added to Cerebral vascular malformations. Sources: Literature Mode of inheritance for gene: NOS3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NOS3 were set to 36941667; 37383439 Phenotypes for gene: NOS3 were set to Moyamoya disease, MONDO:0016820 Review for gene: NOS3 was set to AMBER